// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Incidentally Detected Venous Thromboembolism in Cancer Patients: Results from the Hokusai VTE Cancer Trial

F. Mulder - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

dalteparin Subcutaneous

Risk Factors for Edoxaban‐related Gastrointestinal Bleeding in Patients with Gastrointestinal Cancer: Results from the Hokusai VTE Cancer Study

F.T.M. Bosch - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gastrointestinal bleeding

Edoxaban

A Retrospective Analysis of the real‐world use of Idarucizumab at Two Tertiary Care Centres in Toronto, Canada

J. Abdulrehman - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Idarucizumab

Time from Suspected Thrombotic Thrombocytopenic Purpura to Initiation of Plasma Exchange in Alberta, Canada and Impact on Survival: 10‐year Provincial Retrospective Cohort Study

D. Sawler - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Thrombotic thrombocytopenic purpura

N/A

ADAMTS‐13 Inhibitor Testing Is often Negative on Initial Testing

H. Chaudhry - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Benefit‐risk Assessment of 10mg Daily Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

G.E. Raskob - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

rivaroxaban

Extended‐duration Thromboprophylaxis with Rivaroxaban Reduces the Risk of Major and Fatal Vascular Events in Hospitalized Medically Ill Patients

A.C. Spyropoulos - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

rivaroxaban

Risk Factors Associated with the Failure of Post‐operative Rivaroxaban Thromboprophylaxis in Total Knee Arthoplasty Patients: A Retrospective Case‐control Study

O. Mian - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

rivaroxaban

Gender‐related Differences in Venous Thromboembolism Patients: GARFIELD‐VTE

P. Prandoni - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Risk for Major and Fatal Bleeding After Discontinuing Oral Anticoagulation for Unprovoked Venous Thromboembolism: Systematic Review and Meta‐analysis

F. Khan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Does INR Predict Bleeding Events in Children on Warfarin? A Longitudinal Study

N. Songthawee - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Warfarin

Resumption of Anticoagulant Therapy after Anticoagulant‐related Bleeding: A Population‐Based Cohort Study

D. Little - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Effectof Anticoagulant Treatment on Pain in Distal Deep Vein Thrombosis: An Ancillary Analysis from the CACTUS Trial

M. Righini - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

N/A

Drug‐drug Interactions of Direct Oral Anticoagulants in Clinical Settings: A Systematic Review

A. Li - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Independent Effect of Being a Strict Stockings Complier on the Outcome of the SOX Trial

S. Meleth - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

External Validation of the SOX‐PTS Score (Clinical Prediction Model for the Post‐thrombotic Syndrome) in a Prospective Multicenter Study of Patients with Proximal Deep Vein Thrombosis

A. Rabinovich - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

N/A

An Exploration of the Psychological Impact of Pulmonary Embolism

A. Tran - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Pulmonary embolism

N/A

Identifying Patient Values and Expectations for Pulmonary Embolism CT Scanning in the Emergency Department

V. Swarup - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary embolism

N/A

Complication Rates after Upper Extremity Venous Thrombosis: A Systematic Review and Meta‐analysis

R. Ikesaka - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Diagnostic Accuracy of Limited Versus Whole‐leg Ultrasonography for Suspected Deep Vein Thrombosis: A Systematic Review and Meta‐analysis

N. Kraaijpoel - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Deep vein thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved